Search results
3 days ago · Paxlovid rebound, also known as COVID rebound, is a recurrence of COVID symptoms or a positive test result taken after having the disease and testing negative. Yale experts tell you what you need to know.
Aug 8, 2022 · The CDC defines Paxlovid rebound as when a patient who, after receiving a full five-day course of treatment, either has a reemergence of COVID symptoms or tests positive...
Nov 13, 2023 · Paxlovid is an oral antiviral medication used to treat COVID-19. Previous studies demonstrate the medication’s effectiveness in reducing hospitalization and death in cases of severe COVID-19. Since the integration of Paxlovid into COVID-19 treatment, some patients have reported virologic rebound.
Feb 20, 2024 · What initially was referred to as “Paxlovid rebound”—a return of COVID symptoms or test positivity after starting a course of the antiviral—is now more accurately referred to as “COVID rebound,” because rebound can happen regardless of whether someone takes antivirals.
Sep 26, 2023 · The theory behind Paxlovid rebound is that the treatment is so effective at suppressing the virus that the immune system does not ramp up its cellular and antibody...
- Dani Blum
Feb 1, 2024 · Paxlovid (nirmatrelvir / ritonavir) is an oral antiviral FDA approved to treat mild to moderate COVID-19 in certain people. After finishing a course of Paxlovid, some people get better and then start having symptoms again. This has been referred to as “Paxlovid rebound.”. Rebound COVID symptoms are not a side effect of Paxlovid.
